Cargando…
External Validity of Randomized Controlled Trials on Alzheimer’s Disease: The Biases of Frailty and Biological Aging
To date, the external validity of randomized controlled trials (RCTs) on Alzheimer’s disease (AD) has been assessed only considering monodimensional variables. Nevertheless, looking at isolated and single characteristics cannot guarantee a sufficient level of appreciation of the AD patients’ complex...
Autores principales: | Canevelli, Marco, Trebbastoni, Alessandro, Quarata, Federica, D’Antonio, Fabrizia, Cesari, Matteo, de Lena, Carlo, Bruno, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5712065/ https://www.ncbi.nlm.nih.gov/pubmed/29230192 http://dx.doi.org/10.3389/fneur.2017.00628 |
Ejemplares similares
-
Promoting the Assessment of Frailty in the Clinical Approach to Cognitive Disorders
por: Canevelli, Marco, et al.
Publicado: (2017) -
The Impact of Frailty on the Risk of Conversion from Mild Cognitive Impairment to Alzheimer’s Disease: Evidences from a 5-Year Observational Study
por: Trebbastoni, Alessandro, et al.
Publicado: (2017) -
Sundowning in Dementia: Clinical Relevance, Pathophysiological Determinants, and Therapeutic Approaches
por: Canevelli, Marco, et al.
Publicado: (2016) -
Nutrition and Dementia: Evidence for Preventive Approaches?
por: Canevelli, Marco, et al.
Publicado: (2016) -
Modulation of the Cannabinoid System: A New Perspective for the Treatment of the Alzheimer’s Disease
por: Giuseppina, Talarico, et al.
Publicado: (2019)